RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 53 filers reported holding RECRO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,628 | -57.4% | 12,000 | 0.0% | 0.00% | – |
| Q2 2023 | $13,200 | -7.6% | 12,000 | 0.0% | 0.00% | – |
| Q1 2023 | $14,280 | -20.1% | 12,000 | 0.0% | 0.00% | – |
| Q4 2022 | $17,880 | -38.3% | 12,000 | -33.6% | 0.00% | – |
| Q3 2022 | $29,000 | +107.1% | 18,081 | +0.4% | 0.00% | – |
| Q2 2022 | $14,000 | -56.2% | 18,000 | 0.0% | 0.00% | – |
| Q1 2022 | $32,000 | +3.2% | 18,000 | 0.0% | 0.00% | – |
| Q4 2021 | $31,000 | -16.2% | 18,000 | 0.0% | 0.00% | – |
| Q3 2021 | $37,000 | -11.9% | 18,000 | 0.0% | 0.00% | – |
| Q2 2021 | $42,000 | -16.0% | 18,000 | 0.0% | 0.00% | – |
| Q1 2021 | $50,000 | -2.0% | 18,000 | 0.0% | 0.00% | – |
| Q4 2020 | $51,000 | +34.2% | 18,000 | 0.0% | 0.00% | – |
| Q3 2020 | $38,000 | -53.7% | 18,000 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $82,000 | -61.1% | 18,000 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $211,000 | -36.1% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $330,000 | – | 18,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |